Someone just pulled off genius-level market timing. The moment those weight-loss drugs hit the market, they shorted a plus-size clothing retailer. Company recently got acquired too. That's the kind of second-order thinking most traders completely miss - connecting pharmaceutical breakthroughs to retail sector impacts. While everyone's watching the obvious plays, this person mapped out the downstream effects. Brilliant move.